Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH
Top

07-05-2019 | Systemic lupus erythematosus | Podcast | Article

A closer look at the EULAR guidelines for managing lupus

print
PRINT
insite
SEARCH

Antonis Fanouriakis, lead author of the updated EULAR guidelines for the management of lupus, talks to medwireNews about what’s new in these guidelines and how they will influence clinical practice.

External Content

Click Play to display this content and agree to third party cookies. (>)

Update your current cookie settings.

print
PRINT

Related content

09-04-2019 | Systemic lupus erythematosus | News

Updated EULAR guidelines for lupus management issued

16-10-2018 | Pregnancy | Editorial | Article

Planning and managing pregnancy in lupus patients

20-06-2019 | Systemic lupus erythematosus | Highlight | Article

Systemic lupus erythematosus: Novel therapies and targeted treatments

13-08-2019 | Systemic lupus erythematosus | Editorial | Article

Neuropsychiatric systemic lupus erythematosus: Issues in diagnosis and management
Image Credits